Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular classification in leukemias using gene expression profiling].

Torsten Haferlach1

  • 1Labor für Leukämiediagnostik, Medizinische Klinik III Ludwig-Maximilians-Universität Klinikum Grosshadern, München. torsten.haferlach@med.uni-muenchen.de

Medizinische Klinik (Munich, Germany : 1983)
|August 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classical meets malignant hematology: a case of acquired εγδβ-thalassemia in clonal hematopoiesis.

Haematologica·2024
Same author

Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.

Nature communications·2024
Same author

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia.

Nature communications·2024
Same author

Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML.

bioRxiv : the preprint server for biology·2024
Same author

Prognostic impact of CEBPA mutational subgroups in adult AML.

Leukemia·2024
Same author

Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.

Blood advances·2023
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2014
See all related articles

Gene expression profiling using microarrays offers a powerful molecular approach for leukemia diagnosis, classification, and targeted therapy development. This technology may streamline leukemia diagnostics into a single, robust platform.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Context:

  • Leukemia diagnosis traditionally involves cytomorphology, cytochemistry, cytogenetics, FISH, flow cytometry, and molecular methods.
  • Gene expression profiling (GEP) using microarrays measures thousands of genes simultaneously, providing a molecular fingerprint of tumor samples.

Purpose:

  • To explore the potential of GEP as a novel tool for leukemia diagnosis and molecular classification.
  • To investigate GEP's utility in understanding leukemia pathophysiology, identifying targeted therapies, and enabling minimal residual disease studies.
  • To assess GEP's role in leukemia prognostication and its potential as a single-platform diagnostic approach.

Summary:

  • GEP generates specific molecular signatures for leukemia samples, aiding in more precise classification and insight into disease mechanisms.

Related Experiment Videos

  • GEP facilitates the identification of novel therapeutic targets and genes crucial for monitoring minimal residual disease.
  • Microarray-based GEP shows promise for a unified, rapid, and reliable leukemia diagnostic platform, potentially improving prognostication.

    • Impact:

    • GEP has the potential to revolutionize leukemia diagnostics by offering a comprehensive molecular profile.
    • This technology may lead to the development of personalized targeted therapies and improved monitoring strategies for leukemia patients.
    • Further validation of GEP alongside standard workflows is necessary before it can replace existing diagnostic methods.